Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621530 · ClinicalTrials.gov registry record · Phase 2
Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement
A Phase 2 study, sponsored by Wake Forest University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
NCT00621530 is a Phase 2 study that was terminated before completion, run by Wake Forest University. The registered enrollment target is 62 participants.
The verdict
NCT00621530, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
Study Summary
Chronic pain in patients following total hip replacement seems to be a significant problem. Previous research has shown that more effective pain management in the early postoperative period may decrease the incidence of the development of chronic pain states. This study will evaluate whether ketorolac (a non steroidal anti-inflammatory drug) given into the spinal fluid before surgery will reduce the area of sensitivity (or pain to light touch) following surgery. Patients will be monitored during their postoperative hospital stay and then contacted by telephone at 8 weeks and 6 months after surgery and questioned about any pain they are having at their surgical site. Patients that are still experiencing pain at 6 months will be asked to return to the medical center for the study staff to assess their pain or sensitivity at the surgical site.
Interventions
- DRUG placebo
- DRUG ketorolac tromethamine opthalmic solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00621530
The ClinicalTrials.gov registry entry for NCT00621530 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00621530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00621530 about?
NCT00621530 is a clinical study titled "Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement". Chronic pain in patients following total hip replacement seems to be a significant problem. Previous research has shown that more effective pain management in the early postoperative period may decrease the incidence of the development of chronic pain states. This study will evaluate whether ketoro...
What is the current status of trial NCT00621530?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2008-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00621530?
The interventions under investigation include: placebo (DRUG), ketorolac tromethamine opthalmic solution (DRUG).
Who is sponsoring clinical trial NCT00621530?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.